These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Identification of active-site peptides from 3H-labeled 2-ethynylnaphthalene-inactivated P450 2B1 and 2B4 using amino acid sequencing and mass spectrometry. Roberts ES, Hopkins NE, Zaluzec EJ, Gage DA, Alworth WL, Hollenberg PF. Biochemistry; 1994 Mar 29; 33(12):3766-71. PubMed ID: 8142377 [Abstract] [Full Text] [Related]
4. Mechanistic studies of cytochrome P450 2B1 inactivation by xanthates. Yanev SG, Kent UM, Roberts ES, Ballou DP, Hollenberg PF. Arch Biochem Biophys; 2000 Jun 01; 378(1):157-66. PubMed ID: 10871056 [Abstract] [Full Text] [Related]
5. Role of the alanine at position 363 of cytochrome P450 2B2 in influencing the NADPH- and hydroperoxide-supported activities. Hanna IH, Teiber JF, Kokones KL, Hollenberg PF. Arch Biochem Biophys; 1998 Feb 15; 350(2):324-32. PubMed ID: 9473308 [Abstract] [Full Text] [Related]
6. Mechanism-based inactivation of cytochrome P450 2B1 by 2-ethynylnaphthalene: identification of an active-site peptide. Roberts ES, Hopkins NE, Alworth WL, Hollenberg PF. Chem Res Toxicol; 1993 Feb 15; 6(4):470-9. PubMed ID: 8374044 [Abstract] [Full Text] [Related]
7. Inactivation of cytochrome P450s 2B1, 2B4, 2B6, and 2B11 by arylalkynes. Roberts ES, Hopkins NE, Foroozesh M, Alworth WL, Halpert JR, Hollenberg PF. Drug Metab Dispos; 1997 Nov 15; 25(11):1242-8. PubMed ID: 9351899 [Abstract] [Full Text] [Related]
8. Aryl acetylenes as mechanism-based inhibitors of cytochrome P450-dependent monooxygenase enzymes. Foroozesh M, Primrose G, Guo Z, Bell LC, Alworth WL, Guengerich FP. Chem Res Toxicol; 1997 Jan 15; 10(1):91-102. PubMed ID: 9074808 [Abstract] [Full Text] [Related]
12. Effect of 17-alpha-ethynylestradiol on activities of cytochrome P450 2B (P450 2B) enzymes: characterization of inactivation of P450s 2B1 and 2B6 and identification of metabolites. Kent UM, Mills DE, Rajnarayanan RV, Alworth WL, Hollenberg PF. J Pharmacol Exp Ther; 2002 Feb 15; 300(2):549-58. PubMed ID: 11805216 [Abstract] [Full Text] [Related]
16. Identification of the heme adduct and an active site peptide modified during mechanism-based inactivation of rat liver cytochrome P450 2B1 by secobarbital. He K, Falick AM, Chen B, Nilsson F, Correia MA. Chem Res Toxicol; 1996 Feb 15; 9(3):614-22. PubMed ID: 8728507 [Abstract] [Full Text] [Related]
17. Mechanism-based inactivation of cytochromes P450 2B1 and P450 2B6 by n-propylxanthate. Kent UM, Yanev S, Hollenberg PF. Chem Res Toxicol; 1999 Apr 15; 12(4):317-22. PubMed ID: 10207119 [Abstract] [Full Text] [Related]
18. Suicide inhibitors of cytochrome P450 1A1 and P450 2B1. Hopkins NE, Foroozesh MK, Alworth WL. Biochem Pharmacol; 1992 Aug 18; 44(4):787-96. PubMed ID: 1510726 [Abstract] [Full Text] [Related]
19. Peroxynitrite-mediated nitration of tyrosine and inactivation of the catalytic activity of cytochrome P450 2B1. Roberts ES, Lin Hl, Crowley JR, Vuletich JL, Osawa Y, Hollenberg PF. Chem Res Toxicol; 1998 Sep 18; 11(9):1067-74. PubMed ID: 9760281 [Abstract] [Full Text] [Related]
20. Identification of 17-alpha-ethynylestradiol-modified active site peptides and glutathione conjugates formed during metabolism and inactivation of P450s 2B1 and 2B6. Kent UM, Lin HL, Mills DE, Regal KA, Hollenberg PF. Chem Res Toxicol; 2006 Feb 18; 19(2):279-87. PubMed ID: 16485904 [Abstract] [Full Text] [Related] Page: [Next] [New Search]